Treatment is aimed at normalizing growth hormone (GH) and insulin-like growth factor I (IGF-I) levels, controlling tumor mass, improving associated signs and symptoms, and preventing complications such as cardiovascular disease and respiratory disease [5–8]. This evidence concerns the gene GH1 and respiratory system disorder.